Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

89Zr-DFO-MSTP-2109A shows promise as companion diagnostic in patients with mCRPC

Dec. 4, 2019

First-in-human study of 89Zr-DFO-REGN-3504 for imaging PD-L1 tumors

Nov. 29, 2019

APRINOIA Therapeutics describes compounds targeting microtubule-associated protein tau

Nov. 26, 2019

Aprinoia begins phase II study of tau PET tracer 18F-APN-1607

Nov. 22, 2019

Cerveau Technologies starts Japanese phase I study of [18F]MK-6240

Nov. 15, 2019

NTS2-selective compounds with promising activity in preclinical models of pain

Nov. 4, 2019

(R)-[18F]MH.MZ as a novel PET tracer for the detection of 5-HT2A receptors in the human brain

Oct. 31, 2019

New ultrasensitive tau seed amplification assay for detection and subtyping of 4-repeat tauopathies

Oct. 28, 2019

[68Ga]JMV-6659 shows promising for PET imaging of tumors expressing NTS1

Oct. 23, 2019

[211At]Farletuzumab shows efficacy in a disseminated ovarian cancer mouse model

Oct. 23, 2019

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...